FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1930368505> ?p ?o ?g. }

• W1930368505 endingPage "918" @default.
• W1930368505 startingPage "918" @default.
• W1930368505 abstract "Randomized trials have established the long-term safety and efficacy of hypofractionated whole-breast radiotherapy, but little is known about the acute toxic effects experienced by patients treated with hypofractionation as compared with conventional fractionation, particularly in real-world settings and from the patient's own perspective.To evaluate prospectively collected data on acute toxic effects and patient-reported outcomes in a cohort treated with varying radiation fractionation schemes in practices collaborating in the Michigan Radiation Oncology Quality Consortium (MROQC).We compared toxic effects in patients receiving hypofractionation (HF) vs conventional fractionation (CF) during treatment (through 7 days after treatment) and in follow-up (posttreatment days 8-210), after adjustment for sociodemographic, clinical, and treatment characteristics. The MROQC includes academic and community radiation oncology practices across Michigan. All 2604 patients who received adjuvant whole-breast radiotherapy after lumpectomy for unilateral breast cancer at MROQC participating sites from October 2011 through June 2014 were registered; we analyzed 2309 for whom there was a comprehensive physician toxicity evaluation within 1 week of completion of radiotherapy and at least 1 weekly toxicity evaluation during treatment.Hypofractionation vs CF.Physicians reported dermatitis, pain, fatigue, and other common toxic effects associated with breast radiotherapy at baseline, weekly during radiotherapy, and in follow-up. Patients who consented also rated their own experiences, including breast pain, fatigue, and being bothered by symptoms.Of the 2309 evaluable patients, 578 received HF. During treatment, after adjustment for sociodemographic, clinical, and treatment factors, patients receiving CF had significantly higher maximum physician-assessed skin reaction (moist desquamation, 28.5% vs 6.6%, P < .001; grade ≥2 dermatitis, 62.6% vs 27.4%, P < .001), self-reported pain (moderate/severe pain, 41.1% vs 24.2%, P = .003), burning/stinging bother (often/always, 38.7% vs 15.7%, P = .002), hurting bother (33.5% vs 16.0%, P = .001), swelling bother (29.6% vs 15.7%, P = .03), and fatigue (29.7% vs 18.9%, P = .02) but slightly greater absence of skin induration in follow-up (84.5% vs 81.2%, P = .02). No significant differences were observed in any other measured outcomes during follow-up extending through 6 months.Hypofractionation not only improves convenience but also may reduce acute pain, fatigue, and the extent to which patients are bothered by dermatitis in patients with breast cancer undergoing whole-breast radiotherapy." @default.
• W1930368505 created "2016-06-24" @default.
• W1930368505 creator A5004113579 @default.
• W1930368505 creator A5014527725 @default.
• W1930368505 creator A5017468691 @default.
• W1930368505 creator A5036507987 @default.
• W1930368505 creator A5036540537 @default.
• W1930368505 creator A5053960294 @default.
• W1930368505 creator A5075661070 @default.
• W1930368505 creator A5076973801 @default.
• W1930368505 creator A5078807086 @default.
• W1930368505 creator A5086650245 @default.
• W1930368505 date "2015-10-01" @default.
• W1930368505 modified "2023-10-17" @default.
• W1930368505 title "Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule" @default.
• W1930368505 cites W1529490909 @default.
• W1930368505 cites W1548632059 @default.
• W1930368505 cites W1564392956 @default.
• W1930368505 cites W1603035123 @default.
• W1930368505 cites W1728715977 @default.
• W1930368505 cites W1830334259 @default.
• W1930368505 cites W1968578768 @default.
• W1930368505 cites W1983745214 @default.
• W1930368505 cites W1987423317 @default.
• W1930368505 cites W1990637325 @default.
• W1930368505 cites W2003488831 @default.
• W1930368505 cites W2006079371 @default.
• W1930368505 cites W2015166934 @default.
• W1930368505 cites W2016871222 @default.
• W1930368505 cites W2027501539 @default.
• W1930368505 cites W2030822657 @default.
• W1930368505 cites W2053860026 @default.
• W1930368505 cites W2054693719 @default.
• W1930368505 cites W2070389205 @default.
• W1930368505 cites W2076715153 @default.
• W1930368505 cites W2085332543 @default.
• W1930368505 cites W2091603538 @default.
• W1930368505 cites W2092530442 @default.
• W1930368505 cites W2095393896 @default.
• W1930368505 cites W2096241870 @default.
• W1930368505 cites W2096499183 @default.
• W1930368505 cites W2097823108 @default.
• W1930368505 cites W2103608035 @default.
• W1930368505 cites W2135494402 @default.
• W1930368505 cites W2142045810 @default.
• W1930368505 cites W2143899676 @default.
• W1930368505 cites W2149884878 @default.
• W1930368505 cites W2168124422 @default.
• W1930368505 cites W2320909684 @default.
• W1930368505 doi "https://doi.org/10.1001/jamaoncol.2015.2590" @default.
• W1930368505 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26247417" @default.
• W1930368505 hasPublicationYear "2015" @default.
• W1930368505 type Work @default.
• W1930368505 sameAs 1930368505 @default.
• W1930368505 citedByCount "115" @default.
• W1930368505 countsByYear W19303685052015 @default.
• W1930368505 countsByYear W19303685052016 @default.
• W1930368505 countsByYear W19303685052017 @default.
• W1930368505 countsByYear W19303685052018 @default.
• W1930368505 countsByYear W19303685052019 @default.
• W1930368505 countsByYear W19303685052020 @default.
• W1930368505 countsByYear W19303685052021 @default.
• W1930368505 countsByYear W19303685052022 @default.
• W1930368505 countsByYear W19303685052023 @default.
• W1930368505 crossrefType "journal-article" @default.
• W1930368505 hasAuthorship W1930368505A5004113579 @default.
• W1930368505 hasAuthorship W1930368505A5014527725 @default.
• W1930368505 hasAuthorship W1930368505A5017468691 @default.
• W1930368505 hasAuthorship W1930368505A5036507987 @default.
• W1930368505 hasAuthorship W1930368505A5036540537 @default.
• W1930368505 hasAuthorship W1930368505A5053960294 @default.
• W1930368505 hasAuthorship W1930368505A5075661070 @default.
• W1930368505 hasAuthorship W1930368505A5076973801 @default.
• W1930368505 hasAuthorship W1930368505A5078807086 @default.
• W1930368505 hasAuthorship W1930368505A5086650245 @default.
• W1930368505 hasBestOaLocation W19303685051 @default.
• W1930368505 hasConcept C121608353 @default.
• W1930368505 hasConcept C126322002 @default.
• W1930368505 hasConcept C141071460 @default.
• W1930368505 hasConcept C143998085 @default.
• W1930368505 hasConcept C155806632 @default.
• W1930368505 hasConcept C168563851 @default.
• W1930368505 hasConcept C2777757722 @default.
• W1930368505 hasConcept C2779572924 @default.
• W1930368505 hasConcept C509974204 @default.
• W1930368505 hasConcept C530470458 @default.
• W1930368505 hasConcept C535046627 @default.
• W1930368505 hasConcept C71924100 @default.
• W1930368505 hasConceptScore W1930368505C121608353 @default.
• W1930368505 hasConceptScore W1930368505C126322002 @default.
• W1930368505 hasConceptScore W1930368505C141071460 @default.
• W1930368505 hasConceptScore W1930368505C143998085 @default.
• W1930368505 hasConceptScore W1930368505C155806632 @default.
• W1930368505 hasConceptScore W1930368505C168563851 @default.
• W1930368505 hasConceptScore W1930368505C2777757722 @default.
• W1930368505 hasConceptScore W1930368505C2779572924 @default.
• W1930368505 hasConceptScore W1930368505C509974204 @default.
• W1930368505 hasConceptScore W1930368505C530470458 @default.

• next